Literature DB >> 23981481

PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells.

Qing-Hua Zhao1, Shou-Guo Wang, Shao-Xian Liu, Ji-Peng Li, Yong-Xing Zhang, Zhong-Yi Sun, Qi-Ming Fan, Ji-Wei Tian.   

Abstract

The balance between osteogenesis and adipogenesis of bone marrow stromal cells is impaired in many human diseases. Knowledge of how to fine-tune this balance is of medical importance. CCAAT/enhancer binding protein α (C/EBPα) has been shown to regulate the balance between osteogenesis and adipogenesis of C3H10T1/2 cells, with epigenetic modifications of the C/EBPα promoter playing an important role. The present study aimed to elucidate the underlying molecular mechanisms. The results showed that peroxisome proliferator-activated receptor γ (PPARγ) binds the -1286 bp/-1065 bp region of the C/EBPα promoter to activate C/EBPα expression during osteogenesis and adipogenesis of C3H10T1/2 cells. DNA hypermethylation in the -1286 bp/-1065 bp region, observed at the terminal stage of osteogenesis, prevented PPARγ binding, and then histone deacetylase 1 (HDAC1) occupied this region to reduce the level of histone acetylation. We regulated the balance between osteogenesis and adipogenesis of mouse bone marrow stromal cells through modulation of DNA methylation and histone acetylation status. In addition, in bone marrow stromal cells from the glucocorticoid-induced osteoporosis (GIO) mouse, hypomethylation of CpG sites, higher binding of PPARγ, acetylated histones 3 and 4, and reduced binding of HDAC1 in the -1286 bp/-1065 bp region of C/EBPα promoter were observed, compared with normal mice. This study provides a deeper insight into the molecular mechanisms underlying the balance between osteogenesis and adipogenesis regulated by C/EBPα in synergy with PPARγ, and suggests a molecular model for how DNA methylation and histone acetylation are linked by PPARγ to regulate differentiation of bone marrow stromal cells.
© 2013 FEBS.

Entities:  

Keywords:  C/EBPα; PPARγ; adipogenesis; epigenetics; osteogenesis

Mesh:

Substances:

Year:  2013        PMID: 23981481     DOI: 10.1111/febs.12500

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  22 in total

Review 1.  Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Authors:  Jonathan A R Gordon; Janet L Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  Bone       Date:  2015-03-31       Impact factor: 4.398

2.  Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways.

Authors:  Feng-Sheng Wang; Wei-Shiung Lian; Mel S Lee; Wen-Tsan Weng; Ying-Hsien Huang; Yu-Shan Chen; Yi-Chih Sun; Shing-Long Wu; Pei-Chin Chuang; Jih-Yang Ko
Journal:  J Mol Med (Berl)       Date:  2017-01-27       Impact factor: 4.599

Review 3.  Nutrigenomic regulation of adipose tissue development - role of retinoic acid: A review.

Authors:  Bo Wang; Qiyuan Yang; Corrine L Harris; Mark L Nelson; Jan R Busboom; Mei-Jun Zhu; Min Du
Journal:  Meat Sci       Date:  2016-04-08       Impact factor: 5.209

4.  Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.

Authors:  F-S Wang; W-S Lian; W-T Weng; Y-C Sun; H-J Ke; Y-S Chen; J-Y Ko
Journal:  Osteoporos Int       Date:  2016-04-14       Impact factor: 4.507

5.  Aging-like changes in the transcriptome of irradiated microglia.

Authors:  Matthew D Li; Terry C Burns; Sunny Kumar; Alexander A Morgan; Steven A Sloan; Theo D Palmer
Journal:  Glia       Date:  2015-02-17       Impact factor: 7.452

6.  The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat.

Authors:  Jessica L Pierce; Ke-Hong Ding; Jianrui Xu; Anuj K Sharma; Kanglun Yu; Natalia Del Mazo Arbona; Zuleika Rodriguez-Santos; Paul Bernard; Wendy B Bollag; Maribeth H Johnson; Mark W Hamrick; Dana L Begun; Xing M Shi; Carlos M Isales; Meghan E McGee-Lawrence
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

Review 7.  Recent advances in the epigenetics of bone metabolism.

Authors:  Yuexin Xu; Jing Ma; Guohua Xu; Duan Ma
Journal:  J Bone Miner Metab       Date:  2021-07-11       Impact factor: 2.626

8.  Retinoic acid inhibits white adipogenesis by disrupting GADD45A-mediated Zfp423 DNA demethylation.

Authors:  B Wang; Xing Fu; Mei-Jun Zhu; Min Du
Journal:  J Mol Cell Biol       Date:  2017-08-01       Impact factor: 6.216

9.  JKAMP inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the Wnt signaling pathway through intragenic DNA methylation.

Authors:  Shuanglin Peng; Sirong Shi; Gang Tao; Yanjing Li; Dexuan Xiao; Lang Wang; Qing He; Xiaoxiao Cai; Jingang Xiao
Journal:  Stem Cell Res Ther       Date:  2021-02-12       Impact factor: 6.832

10.  Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis.

Authors:  E'Lissa M Flores; Collynn F Woeller; Megan L Falsetta; Martha Susiarjo; Richard P Phipps
Journal:  FASEB J       Date:  2018-10-30       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.